vs
Side-by-side financial comparison of CECO ENVIRONMENTAL CORP (CECO) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $205.9M, roughly 1.0× CECO ENVIRONMENTAL CORP).
CECO Environmental Corp. is an American industrial technology company founded in 1966 and headquartered in Dallas, Texas. It is publicly traded on the Nasdaq Stock Market under the ticker symbol CECO. The company provides air pollution control technology, products, and services for industrial markets, including manufacturing, chemical processing, energy, and refining.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
CECO vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.9M | $207.8M |
| Net Profit | — | $119.2M |
| Gross Margin | 31.0% | — |
| Operating Margin | 0.9% | 52.2% |
| Net Margin | — | 57.4% |
| Revenue YoY | 16.5% | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $0.98 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $205.9M | — | ||
| Q4 25 | $214.7M | — | ||
| Q3 25 | $197.6M | $207.8M | ||
| Q2 25 | $185.4M | — | ||
| Q1 25 | $176.7M | — | ||
| Q4 24 | $158.6M | — | ||
| Q3 24 | $135.5M | $0 | ||
| Q2 24 | $137.5M | $0 |
| Q1 26 | — | — | ||
| Q4 25 | $3.1M | — | ||
| Q3 25 | $1.5M | $119.2M | ||
| Q2 25 | $9.5M | — | ||
| Q1 25 | $36.0M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $2.1M | $-51.8M | ||
| Q2 24 | $4.5M | $-52.8M |
| Q1 26 | 31.0% | — | ||
| Q4 25 | 35.1% | — | ||
| Q3 25 | 32.7% | — | ||
| Q2 25 | 36.2% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 35.8% | — | ||
| Q3 24 | 33.4% | — | ||
| Q2 24 | 35.7% | — |
| Q1 26 | 0.9% | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 4.8% | 52.2% | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 6.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.8% | 57.4% | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.3% | — |
| Q1 26 | $0.98 | — | ||
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.04 | $1.33 | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.98 | — | ||
| Q4 24 | $0.14 | — | ||
| Q3 24 | $0.06 | $-0.60 | ||
| Q2 24 | $0.12 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.4M | $786.9M |
| Total DebtLower is stronger | $5.3M | — |
| Stockholders' EquityBook value | $317.2M | $1.1B |
| Total Assets | $1.0B | $1.2B |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $45.4M | — | ||
| Q4 25 | $33.1M | — | ||
| Q3 25 | $32.8M | $786.9M | ||
| Q2 25 | $36.8M | — | ||
| Q1 25 | $146.5M | — | ||
| Q4 24 | $37.8M | — | ||
| Q3 24 | $38.7M | $920.0M | ||
| Q2 24 | $36.5M | $701.7M |
| Q1 26 | $5.3M | — | ||
| Q4 25 | $212.4M | — | ||
| Q3 25 | $220.9M | — | ||
| Q2 25 | $238.7M | — | ||
| Q1 25 | $339.7M | — | ||
| Q4 24 | $218.9M | — | ||
| Q3 24 | $133.4M | — | ||
| Q2 24 | $130.8M | — |
| Q1 26 | $317.2M | — | ||
| Q4 25 | $317.5M | — | ||
| Q3 25 | $309.2M | $1.1B | ||
| Q2 25 | $298.4M | — | ||
| Q1 25 | $285.8M | — | ||
| Q4 24 | $247.7M | — | ||
| Q3 24 | $241.3M | $1.2B | ||
| Q2 24 | $235.0M | $931.7M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $893.8M | — | ||
| Q3 25 | $891.9M | $1.2B | ||
| Q2 25 | $876.6M | — | ||
| Q1 25 | $957.1M | — | ||
| Q4 24 | $759.7M | — | ||
| Q3 24 | $621.5M | $1.2B | ||
| Q2 24 | $598.1M | $973.7M |
| Q1 26 | 0.02× | — | ||
| Q4 25 | 0.67× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.56× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.0M | — | ||
| Q3 25 | $15.3M | $142.2M | ||
| Q2 25 | $-7.7M | — | ||
| Q1 25 | $-11.7M | — | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $15.1M | $-49.2M | ||
| Q2 24 | $6.7M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | — | ||
| Q3 25 | $11.0M | $142.2M | ||
| Q2 25 | $-8.7M | — | ||
| Q1 25 | $-15.1M | — | ||
| Q4 24 | $-4.3M | — | ||
| Q3 24 | $11.1M | $-49.7M | ||
| Q2 24 | $2.5M | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | — | ||
| Q3 25 | 5.6% | 68.4% | ||
| Q2 25 | -4.7% | — | ||
| Q1 25 | -8.5% | — | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 1.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 3.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.26× | — | ||
| Q3 25 | 10.18× | 1.19× | ||
| Q2 25 | -0.81× | — | ||
| Q1 25 | -0.33× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 7.24× | — | ||
| Q2 24 | 1.49× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
